期刊文献+

离线紫外照射和高效液相荧光法测定他莫昔芬及代谢物在人血浆中的浓度 被引量:2

Determination of Tamoxifen and Two Metabolites in Human Plasma by Offline UV Irradiation and High Performance Liquid Chromatography with Fluorescence
原文传递
导出
摘要 目的建立高效液相荧光法测定人血浆中他莫昔芬及主要代谢物浓度。方法血浆样品经正己烷-正丁醇(98∶2)提取后,以甲醇-1%三乙胺水溶液(82∶18)为流动相,流速为1mL·min-1,色谱柱为Agilent Extend C18(4.6mm×150mm,5μm),柱温为50℃,离线紫外照射(254nm)10.5min,使目标化合物转变成强荧光性的菲衍生物,荧光检测波长:激发波长(λex)260nm,发射波长(λem)375nm。结果血浆内源性杂质不干扰待测物测定,线性范围分别为:他莫昔芬为0.5~200μg·L-1;N-去甲他莫昔芬为0.5~300μg·L-1;4-羟基他莫昔芬为0.1~10μg·L-1。日内、日间精密度(RSD)均小于10%。样品4次冻融,以及在提取后,4℃下12h内稳定性良好。结论该法灵敏、快速、准确,操作简便、线性范围宽,可用于他莫昔芬的药动学研究及常规治疗药物监测。 OBJECTIVE To establish a high performance liquid chromatography with fluorescence detector for the determination of tamoxifen and two metabolites in human plasma.METHODS Plasma samples were extracted by n-hexane n-butanol(98 : 2). Offiine UV wavelength of 254 nm was used to convert the target compounds to highly fluorescence phenanthrene derivates for 10.5 min. Separation was carrid out on the Agilent Extend C18 column (4.6 mm×150 mm, 5 μm) at 50 ℃. The mobile phase consisted of methanol -1% triethylamine (82 : 18) at a flow rate of 1 mL·min^-1. The fluorescence detector was operated at excitation wavelength of 260 nm and emission wavelength of 375 nm, respectively. RESULTS The intrinsic impurity of plasma did not interfere with the determination. The linear range of tamoxifen was 0.5-200 μg·L^-1. The linear range of N-desmethyltamoxifen was 0.5-300 μg·L^-1. The linear range of 4-hydroxytamoxifen was 0.1-10μg·L^-1. The within-day and between-day precisions were less than 10%. The stability of unprocessed and processed samples stored 12 h at 4 ℃ was good.After 4 cycles of freeze and thaw processes, the plasma samples were stable.CONCLUSION The established HPLC method is rapid, sensitive, accurate and can be applied to the clinical pharmacokinetic research and routine therapeutic drug monitoring.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第21期1658-1661,共4页 Chinese Pharmaceutical Journal
基金 南京医科大学科技发展基金项目(06NMUM062)
关键词 他莫昔芬 N-去甲他莫昔芬 4-羟基他莫昔芬 高效液相荧光法 tamoxifen N-desmethyltamoxifen(NDT) 4-hydroxytamoxifen(4-OHT) HPLC-FLU
  • 相关文献

参考文献1

  • 1Louis W.C. Chow,Wings T.Y. Loo. The Differential Effects of Cyclophosphamide, Epirubicin and 5-Fluorouracil on Apoptotic Marker (CPP-32), Pro-Apoptotic Protein (p21 WAF?1) and Anti-Apoptotic Protein (bcl-2) in Breast Cancer Cells[J] 2003,Breast Cancer Research and Treatment(3):239~244

同被引文献23

  • 1刘玉华,李太平.高效液相色谱法测定枸橼酸他莫昔芬片的含量[J].色谱,1995,13(6):483-484. 被引量:9
  • 2谢林,刘晓东,龚小健,刘国卿.枸橼酸他莫昔芬片剂的药代动力学和相对生物利用度研究[J].中国药科大学学报,1995,26(2):84-86. 被引量:7
  • 3梁宇光,高洪志,林丽娜,胡锦超,刘泽源.枸橼酸他莫昔芬缓释片在健康人体的生物等效性[J].中国临床药理学杂志,2007,23(3):195-198. 被引量:3
  • 4Lien EA, Ueland PM, Solheim E, et al. Determina- tion of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography [J]. Clin Chem, 1987,33(9) :1608-1614.
  • 5El-Yazigi A, Legayada E. Direct liquid chromato- graphic micro-measurement of tamoxifen in plasma of cancer patients[J].J Chromatogr B Biomed Sci Appl, 1997, 691(2):457-462.
  • 6Zhu YB, Zhang Q, Zou JJ, et al. Optimizing high- performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metaholites in human plasma: application to a clinical study[J]. J Pharm Biomed Anal, 2008,46 (2) :349-355.
  • 7Dahmane E, Mercier T, Zanolari B, et al. An ultra performance liquid chromatography-tandem MS as- say for tamoxifen metabolites profiling in plasma: first evidence of 4 "-hydroxylated metabolites in breast cancer patients[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2010, 878 (32): 3402- 3414.
  • 8Gjerde J, Kisanga ER, Hauglid M, et al. Identifi cation and quantification of tamoxifen and four me-tabolites in serum by liquid chromatography-tandem mass spectrometry[J].J Chromatogr A, 2005,1082 (1):6-14.
  • 9刘先军,张晶,邵兵,等.固相萃取一液相色谱串联质谱法测定城市污水中他莫昔芬和来曲唑[J].分析化学研究报告,20lO,3(2):214—218.
  • 10Lim CK, Yuan ZX, Jones RM, et al. Identification and mechanism of formation of potentially genotoxie metabolites of tamoxifen: study by LC-MS/MS[J].J Pharm Biomed Anal, 1997, 15 (9/10): 1335- 1342.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部